trial · primary record
COR-1004
Hyperlipidemia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2027-11 |
| Primary endpoint | Occurrence of Clinical and Laboratory Adverse Events within 90 Days post COR-1004 administration |
| Registry ID | NCT07229118 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:19.273Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07229118
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.